We are live on ! Find out more
PCPC.WS

Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75

Delisted

PCPC.WS was delisted on the 30th of November, 2022.

29 hedge funds and large institutions have $2.96M invested in Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more capital invested

Capital invested by funds: $2.57M → $2.96M (+$384K)

9% less funds holding

Funds holding: 3229 (-3)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
29
Holders Change
-3
Holders Change %
-9.38%
% of All Funds
0.49%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
4
Closed
7
Calls
$21K
Puts
Net Calls
+$21K
Net Calls Change
-$15K

PCPC.WS Hedge Fund Activity: Q2 2022 in Review

29 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 (PCPC.WS) for Q2 2022, worth a combined $2.96M — up 15% from $2.57M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of PCPC.WS and 4 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 2 added.

The largest buyer was Shaolin Capital Management, adding an estimated $25.9K. The largest seller was Empyrean Capital Partners, exiting entirely with an estimated $161K sold.

  • 29 institutional investors held Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 (PCPC.WS) as of Q2 2022, down from 32 in Q1 2022.
  • Funds reported $2.96M of Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 stock for Q2 2022, up 15% quarter-over-quarter.
  • 4 funds opened new Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 positions in Q2 2022 and 7 closed out, a net change of -3 holders.
  • The largest Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 buyer in Q2 2022 was Shaolin Capital Management, an estimated $25.9K added.
  • The largest Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 seller in Q2 2022 was Empyrean Capital Partners, an estimated $161K sold.

Based on aggregated 13F filings for Q2 2022.